The narrative presents Portugal's biotech sector as a rising star, leveraging academic spin-offs, strategic partnerships, and government support to carve a niche in precision medicine and infectious disease. The strongest version of this story highlights genuine innovation—Beat Therapeutics' DDR inhibitors, Immunethep's antibiotic resistance solutions, and Exogenus' exosome platform all address unmet medical needs with novel mechanisms. The hosting of BIO-Europe Spring in Lisbon serves as both v...